Evidence map›Paper›PMID 40177166›Full record

SynthesisFrontiers in human neuroscience2025

Human induced pluripotent stem cell models for Alzheimer's disease research: a bibliometric analysis.

Yuning Sun, Zhilong Liu, Zongbo Zhang, Yufeng Kang, Xinlian Wang, Yiping Zhang, Yan Liu, Pei Zhao

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuning Sun *School of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, China.
Zhilong Liu *Gansu Provincial People's Hospital, Lanzhou, China.
Zongbo ZhangSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Yufeng KangSchool of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, China.
Xinlian WangSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Yiping ZhangSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Yan LiuSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Pei ZhaoSchool of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alzheimer's disease (AD), the leading cause of dementia, remains without adequate treatment. Current models do not fully replicate human physiology and pathology. The advent of human induced pluripotent stem cell (hiPSC) technology offers a novel approach to studying AD. Methods: Our study conducted a bibliometric analysis to assess the application and development of hiPSC technology in AD research. We retrieved 531 articles on hiPSC models of AD from the Web of Science Core Collection, published between January 2010 and June 2024. CiteSpace and VOSviewer were used to analyze authorship, geographic contributions, journal influence, and citation patterns. Results: Our findings reveal a steady increase in publications over 14 years, with the United States leading in contributions, followed by China. Li-Huei Tsai from the Massachusetts Institute of Technology is a prominent researcher. Discussion: Bibliometric analysis is crucial in identifying research gaps and trends and guiding future studies to address unmet needs in understanding and modeling human physiology and pathology. Leveraging hiPSC models to investigate the molecular mechanisms of familial and sporadic AD is expected to provide a crucial foundation for developing future treatment strategies. Conclusion: In summary, the bibliometric findings from this study provide a comprehensive overview of the current research landscape in hiPSC models for AD. It also highlights emerging trends and research gaps, crucial for guiding future research efforts, particularly in exploring novel therapeutic targets and improving understanding of disease mechanisms.

Indexed as

Alzheimer’s disease (AD)apolipoprotein E (ApoE)bibliometricshuman induced pluripotent stem cell (hiPSC)inflammation

Identifiers

PMID40177166
PMCPMC11962003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.